| Literature DB >> 32396847 |
Jean-Christophe Beltra1, Sasikanth Manne2, Mohamed S Abdel-Hakeem3, Makoto Kurachi4, Josephine R Giles1, Zeyu Chen2, Valentina Casella5, Shin Foong Ngiow1, Omar Khan6, Yinghui Jane Huang2, Patrick Yan6, Kito Nzingha2, Wei Xu7, Ravi K Amaravadi7, Xiaowei Xu8, Giorgos C Karakousis9, Tara C Mitchell7, Lynn M Schuchter7, Alexander C Huang10, E John Wherry11.
Abstract
CD8+ T cell exhaustion is a major barrier to current anti-cancer immunotherapies. Despite this, the developmental biology of exhausted CD8+ T cells (Tex) remains poorly defined, restraining improvement of strategies aimed at "re-invigorating" Tex cells. Here, we defined a four-cell-stage developmental framework for Tex cells. Two TCF1+ progenitor subsets were identified, one tissue restricted and quiescent and one more blood accessible, that gradually lost TCF1 as it divided and converted to a third intermediate Tex subset. This intermediate subset re-engaged some effector biology and increased upon PD-L1 blockade but ultimately converted into a fourth, terminally exhausted subset. By using transcriptional and epigenetic analyses, we identified the control mechanisms underlying subset transitions and defined a key interplay between TCF1, T-bet, and Tox in the process. These data reveal a four-stage developmental hierarchy for Tex cells and define the molecular, transcriptional, and epigenetic mechanisms that could provide opportunities to improve cancer immunotherapy.Entities:
Keywords: CD8; PD-1 blockade; T cell exhaustion lineage; T-bet; TCF1; Tox; cancer immunotherapy; chronic infection; epigenetics; exhaustion
Mesh:
Substances:
Year: 2020 PMID: 32396847 DOI: 10.1016/j.immuni.2020.04.014
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745